APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Impetigo Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Impetigo Drug Industry Growth and Trends Forecast to 2032

Report ID 174002230119 December 202592 pages

Choose your research edition.

Industry ResearchImpetigo Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Impetigo Drug Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Impetigo Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Impetigo Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Impetigo Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Impetigo Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Impetigo Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Impetigo Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Impetigo Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Impetigo Drug include Lytix Biopharma AS, Laboratories Ojer Pharma SL, Fujifilm Holdings Corporation, Foamix Pharmaceuticals Ltd and Destiny Pharma Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Impetigo Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Impetigo Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Impetigo Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Impetigo Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Impetigo Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Impetigo Drug Market by Company

Lytix Biopharma AS

Laboratories Ojer Pharma SL

Fujifilm Holdings Corporation

Foamix Pharmaceuticals Ltd

Destiny Pharma Ltd

Impetigo Drug Segment by Type

Mupirocin

Ozenoxacin

LTX-109

FMX-102

Others

Impetigo Drug Segment by Application

Clinic

Hospital

Others

Impetigo Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Impetigo Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Impetigo Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Impetigo Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Impetigo Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Impetigo Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Mupirocin Table 2. Major Company of Ozenoxacin Table 3. Major Company of LTX-109 Table 4. Major Company of FMX-102 Table 5. Major Company of Others Table 6. Global Impetigo Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Impetigo Drug Sales by Type (2021-2026) & (K Units) Table 8. Global Impetigo Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Impetigo Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Impetigo Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Impetigo Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Impetigo Drug Sales by Type (2027-2032) & (K Units) Table 13. Global Impetigo Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Impetigo Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Impetigo Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Impetigo Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Impetigo Drug Sales by Type (2021-2026) & (K Units) Table 18. North America Impetigo Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Impetigo Drug Sales by Type (2021-2026) & (K Units) Table 20. Europe Impetigo Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Impetigo Drug Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Impetigo Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Impetigo Drug Sales by Type (2021-2026) & (K Units) Table 24. Latin America Impetigo Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Impetigo Drug Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Impetigo Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Impetigo Drug Industry Trends Table 28. Impetigo Drug Industry Drivers Table 29. Impetigo Drug Industry Opportunities and Challenges Table 30. Impetigo Drug Industry Restraints Table 31. Global Impetigo Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Impetigo Drug Revenue Market Share by Company (2021-2026) Table 33. Global Impetigo Drug Sales by Company (2021-2026) & (K Units) Table 34. Global Impetigo Drug Sales Share by Company (2021-2026) Table 35. Global Impetigo Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Impetigo Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Impetigo Drug Major Company Production Sites and Headquarters Table 38. Global Impetigo Drug Company, Product Type & Application Table 39. Global Impetigo Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Impetigo Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Impetigo Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Impetigo Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Impetigo Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Impetigo Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Impetigo Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Impetigo Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Impetigo Drug Sales by Region (2027-2032) & (K Units) Table 49. Global Impetigo Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Impetigo Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Impetigo Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Impetigo Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Impetigo Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Impetigo Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Impetigo Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Impetigo Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Impetigo Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Impetigo Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Impetigo Drug Sales by Application (2027-2032) & (K Units) Table 60. Global Impetigo Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Impetigo Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Impetigo Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Impetigo Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Impetigo Drug Sales by Application (2021-2026) & (K Units) Table 65. North America Impetigo Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Impetigo Drug Sales by Application (2021-2026) & (K Units) Table 67. Europe Impetigo Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Impetigo Drug Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Impetigo Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Impetigo Drug Sales by Application (2021-2026) & (K Units) Table 71. Latin America Impetigo Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Impetigo Drug Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Impetigo Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Lytix Biopharma AS Company Information Table 75. Lytix Biopharma AS Business Overview Table 76. Lytix Biopharma AS Impetigo Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Lytix Biopharma AS Impetigo Drug Product Portfolio Table 78. Lytix Biopharma AS Recent Development Table 79. Laboratories Ojer Pharma SL Company Information Table 80. Laboratories Ojer Pharma SL Business Overview Table 81. Laboratories Ojer Pharma SL Impetigo Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Laboratories Ojer Pharma SL Impetigo Drug Product Portfolio Table 83. Laboratories Ojer Pharma SL Recent Development Table 84. Fujifilm Holdings Corporation Company Information Table 85. Fujifilm Holdings Corporation Business Overview Table 86. Fujifilm Holdings Corporation Impetigo Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Fujifilm Holdings Corporation Impetigo Drug Product Portfolio Table 88. Fujifilm Holdings Corporation Recent Development Table 89. Foamix Pharmaceuticals Ltd Company Information Table 90. Foamix Pharmaceuticals Ltd Business Overview Table 91. Foamix Pharmaceuticals Ltd Impetigo Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Foamix Pharmaceuticals Ltd Impetigo Drug Product Portfolio Table 93. Foamix Pharmaceuticals Ltd Recent Development Table 94. Destiny Pharma Ltd Company Information Table 95. Destiny Pharma Ltd Business Overview Table 96. Destiny Pharma Ltd Impetigo Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Destiny Pharma Ltd Impetigo Drug Product Portfolio Table 98. Destiny Pharma Ltd Recent Development Table 99. North America Impetigo Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 100. North America Impetigo Drug Sales by Country (2021-2026) & (K Units) Table 101. North America Impetigo Drug Sales Market Share by Country (2021-2026) Table 102. North America Impetigo Drug Sales Forecast by Country (2027-2032) & (K Units) Table 103. North America Impetigo Drug Sales Market Share Forecast by Country (2027-2032) Table 104. North America Impetigo Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Impetigo Drug Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Impetigo Drug Market Share by Country (2021-2026) Table 107. North America Impetigo Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Impetigo Drug Market Share Forecast by Country (2027-2032) Table 109. Europe Impetigo Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. Europe Impetigo Drug Sales by Country (2021-2026) & (K Units) Table 111. Europe Impetigo Drug Sales Market Share by Country (2021-2026) Table 112. Europe Impetigo Drug Sales Forecast by Country (2027-2032) & (K Units) Table 113. Europe Impetigo Drug Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Impetigo Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Impetigo Drug Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Impetigo Drug Market Share by Country (2021-2026) Table 117. Europe Impetigo Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Impetigo Drug Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Impetigo Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Impetigo Drug Sales by Country (2021-2026) & (K Units) Table 121. Asia-Pacific Impetigo Drug Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Impetigo Drug Sales Forecast by Country (2027-2032) & (K Units) Table 123. Asia-Pacific Impetigo Drug Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Impetigo Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Impetigo Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Impetigo Drug Market Share by Country (2021-2026) Table 127. Asia-Pacific Impetigo Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Impetigo Drug Market Share Forecast by Country (2027-2032) Table 129. Latin America Impetigo Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Latin America Impetigo Drug Sales by Country (2021-2026) & (K Units) Table 131. Latin America Impetigo Drug Sales Market Share by Country (2021-2026) Table 132. Latin America Impetigo Drug Sales Forecast by Country (2027-2032) & (K Units) Table 133. Latin America Impetigo Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Impetigo Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Impetigo Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Impetigo Drug Market Share by Country (2021-2026) Table 137. Latin America Impetigo Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Impetigo Drug Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Impetigo Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Impetigo Drug Sales by Country (2021-2026) & (K Units) Table 141. Middle East and Africa Impetigo Drug Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Impetigo Drug Sales Forecast by Country (2027-2032) & (K Units) Table 143. Middle East and Africa Impetigo Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Impetigo Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Impetigo Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Impetigo Drug Market Share by Country (2021-2026) Table 147. Middle East and Africa Impetigo Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Impetigo Drug Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Impetigo Drug Distributors List Table 152. Impetigo Drug Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Impetigo Drug Image Figure 2. Global Impetigo Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Impetigo Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Impetigo Drug Sales (2021-2032) & (K Units) Figure 5. Mupirocin Image Figure 6. Global Mupirocin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Ozenoxacin Image Figure 8. Global Ozenoxacin Sales YoY Growth (2021-2032) & (K Units) Figure 9. LTX-109 Image Figure 10. Global LTX-109 Sales YoY Growth (2021-2032) & (K Units) Figure 11. FMX-102 Image Figure 12. Global FMX-102 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Impetigo Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Impetigo Drug Market Share by Type 2025 VS 2032 Figure 17. North America Impetigo Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Impetigo Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Impetigo Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Impetigo Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Impetigo Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Impetigo Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Impetigo Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Impetigo Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Impetigo Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Impetigo Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Impetigo Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Impetigo Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Impetigo Drug Market Share by Application 2025 VS 2032 Figure 37. North America Impetigo Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Impetigo Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Impetigo Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Impetigo Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Impetigo Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Impetigo Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Impetigo Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Impetigo Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Impetigo Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Impetigo Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Impetigo Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Impetigo Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Impetigo Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Impetigo Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Impetigo Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Impetigo Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Impetigo Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Impetigo Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Impetigo Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Impetigo Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Impetigo Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Impetigo Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Impetigo Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Impetigo Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Impetigo Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Impetigo Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Impetigo Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Impetigo Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Impetigo Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Impetigo Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Impetigo Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Impetigo Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Mupirocin
  • Ozenoxacin
  • LTX-109
  • FMX-102
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Lytix Biopharma AS
  • Laboratories Ojer Pharma SL
  • Fujifilm Holdings Corporation
  • Foamix Pharmaceuticals Ltd
  • Destiny Pharma Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Impetigo Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Impetigo Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Impetigo Drug Market by Type
  6. 1.3.1 Mupirocin
  7. 1.3.2 Ozenoxacin
  8. 1.3.3 LTX-109
  9. 1.3.4 FMX-102
  10. 1.3.5 Others
  11. 1.4 Global Impetigo Drug Market Size by Type
  12. 1.4.1 Global Impetigo Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Impetigo Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Impetigo Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Impetigo Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Impetigo Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Impetigo Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Impetigo Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Impetigo Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Impetigo Drug Industry Trends
  2. 2.2 Impetigo Drug Industry Drivers
  3. 2.3 Impetigo Drug Industry Opportunities and Challenges
  4. 2.4 Impetigo Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Impetigo Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Impetigo Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Impetigo Drug Price (2021-2026)
  4. 3.4 Global Impetigo Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Impetigo Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Impetigo Drug Company, Product Type & Application
  7. 3.7 Global Impetigo Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Impetigo Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Impetigo Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Impetigo Drug Tier 1, Tier 2, and Tier 3
4 Impetigo Drug Regional Status and Outlook
  1. 4.1 Global Impetigo Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Impetigo Drug Historic Market Size by Region
  3. 4.2.1 Global Impetigo Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Impetigo Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Impetigo Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Impetigo Drug Forecasted Market Size by Region
  7. 4.3.1 Global Impetigo Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Impetigo Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Impetigo Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Impetigo Drug by Application
  1. 5.1 Impetigo Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Impetigo Drug Market Size by Application
  6. 5.2.1 Global Impetigo Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Impetigo Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Impetigo Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Impetigo Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Impetigo Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Impetigo Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Impetigo Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Impetigo Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Lytix Biopharma AS
  2. 6.1.1 Lytix Biopharma AS Company Information
  3. 6.1.2 Lytix Biopharma AS Business Overview
  4. 6.1.3 Lytix Biopharma AS Impetigo Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Lytix Biopharma AS Impetigo Drug Product Portfolio
  6. 6.1.5 Lytix Biopharma AS Recent Developments
  7. 6.2 Laboratories Ojer Pharma SL
  8. 6.2.1 Laboratories Ojer Pharma SL Company Information
  9. 6.2.2 Laboratories Ojer Pharma SL Business Overview
  10. 6.2.3 Laboratories Ojer Pharma SL Impetigo Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Laboratories Ojer Pharma SL Impetigo Drug Product Portfolio
  12. 6.2.5 Laboratories Ojer Pharma SL Recent Developments
  13. 6.3 Fujifilm Holdings Corporation
  14. 6.3.1 Fujifilm Holdings Corporation Company Information
  15. 6.3.2 Fujifilm Holdings Corporation Business Overview
  16. 6.3.3 Fujifilm Holdings Corporation Impetigo Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fujifilm Holdings Corporation Impetigo Drug Product Portfolio
  18. 6.3.5 Fujifilm Holdings Corporation Recent Developments
  19. 6.4 Foamix Pharmaceuticals Ltd
  20. 6.4.1 Foamix Pharmaceuticals Ltd Company Information
  21. 6.4.2 Foamix Pharmaceuticals Ltd Business Overview
  22. 6.4.3 Foamix Pharmaceuticals Ltd Impetigo Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Foamix Pharmaceuticals Ltd Impetigo Drug Product Portfolio
  24. 6.4.5 Foamix Pharmaceuticals Ltd Recent Developments
  25. 6.5 Destiny Pharma Ltd
  26. 6.5.1 Destiny Pharma Ltd Company Information
  27. 6.5.2 Destiny Pharma Ltd Business Overview
  28. 6.5.3 Destiny Pharma Ltd Impetigo Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Destiny Pharma Ltd Impetigo Drug Product Portfolio
  30. 6.5.5 Destiny Pharma Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Impetigo Drug Sales by Country
  2. 7.1.1 North America Impetigo Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Impetigo Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Impetigo Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Impetigo Drug Market Size by Country
  6. 7.2.1 North America Impetigo Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Impetigo Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Impetigo Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Impetigo Drug Sales by Country
  2. 8.1.1 Europe Impetigo Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Impetigo Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Impetigo Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Impetigo Drug Market Size by Country
  6. 8.2.1 Europe Impetigo Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Impetigo Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Impetigo Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Impetigo Drug Sales by Country
  2. 9.1.1 Asia-Pacific Impetigo Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Impetigo Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Impetigo Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Impetigo Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Impetigo Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Impetigo Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Impetigo Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Impetigo Drug Sales by Country
  2. 10.1.1 South America Impetigo Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Impetigo Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Impetigo Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Impetigo Drug Market Size by Country
  6. 10.2.1 South America Impetigo Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Impetigo Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Impetigo Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Impetigo Drug Sales by Country
  2. 11.1.1 Middle East and Africa Impetigo Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Impetigo Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Impetigo Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Impetigo Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Impetigo Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Impetigo Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Impetigo Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Impetigo Drug Value Chain Analysis
  2. 12.1.1 Impetigo Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Impetigo Drug Production Mode & Process
  7. 12.2 Impetigo Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Impetigo Drug Distributors
  10. 12.2.3 Impetigo Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst